Nkarta Inc is a biotechnology business based in the US. Nkarta Inc shares (NKTX) are listed on the NASDAQ and all prices are listed in US Dollars. Nkarta Inc employs 127 staff and has a trailing 12-month revenue of around $385.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Active traders
| Latest market close | $13.15 |
|---|---|
| 52-week range | $7.55 - $26.69 |
| 50-day moving average | $14.40 |
| 200-day moving average | $12.86 |
| Wall St. target price | $39.60 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.82 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $13.15 from 2022-10-03
| 1 week (2022-09-27) | 4.20% |
|---|---|
| 1 month (2022-09-01) | N/A |
| 3 months (2022-07-05) | -5.87% |
| 6 months (2022-04-05) | 9.49% |
| 1 year (2021-10-05) | -49.54% |
|---|---|
| 2 years (2020-10-05) | -59.33% |
| 3 years (2019-10-01) | N/A |
| 5 years (2017-10-01) | N/A |
| Revenue TTM | $385 |
|---|---|
| Gross profit TTM | $-36,220,000 |
| Return on assets TTM | -15.23% |
| Return on equity TTM | -27.65% |
| Profit margin | 0% |
| Book value | $8.69 |
| Market capitalisation | $651.5 million |
TTM: trailing 12 months
We're not expecting Nkarta Inc to pay a dividend over the next 12 months.
Over the last 12 months, Nkarta Inc's shares have ranged in value from as little as $7.55 up to $26.689. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nkarta Inc's is 0.0672. This would suggest that Nkarta Inc's shares are less volatile than average (for this exchange).
Nkarta, Inc. , a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
Our list of 10 dividend stocks to watch in 2022.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.